LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report)'s stock price gapped up before the market opened on Monday . The stock had previously closed at $7.17, but opened at $7.59. LifeStance Health Group shares last traded at $7.61, with a volume of 217,663 shares changing hands.
Analyst Ratings Changes
Several brokerages have weighed in on LFST. Barclays increased their target price on LifeStance Health Group from $6.00 to $7.00 and gave the stock an "underweight" rating in a research report on Monday, November 11th. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $10.00 price target for the company in a research report on Monday. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $8.70.
Get Our Latest Stock Report on LifeStance Health Group
LifeStance Health Group Stock Up 8.1 %
The company has a market cap of $2.97 billion, a price-to-earnings ratio of -29.81 and a beta of 1.28. The stock has a 50-day simple moving average of $7.19 and a 200-day simple moving average of $6.35. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19.
LifeStance Health Group (NASDAQ:LFST - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.05. The business had revenue of $312.70 million during the quarter, compared to the consensus estimate of $302.25 million. LifeStance Health Group had a negative net margin of 7.90% and a negative return on equity of 6.66%. The company's quarterly revenue was up 18.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.17) earnings per share. As a group, analysts predict that LifeStance Health Group, Inc. will post -0.2 EPS for the current year.
Insider Activity
In related news, Director Robert Bessler sold 75,000 shares of the business's stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $7.54, for a total transaction of $565,500.00. Following the sale, the director now owns 1,424,447 shares of the company's stock, valued at $10,740,330.38. The trade was a 5.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 6.60% of the company's stock.
Hedge Funds Weigh In On LifeStance Health Group
Several hedge funds have recently modified their holdings of the company. Point72 Asset Management L.P. acquired a new position in shares of LifeStance Health Group in the 2nd quarter worth approximately $4,326,000. Geode Capital Management LLC boosted its holdings in LifeStance Health Group by 26.8% during the third quarter. Geode Capital Management LLC now owns 3,452,178 shares of the company's stock worth $24,170,000 after buying an additional 729,794 shares in the last quarter. Wellington Management Group LLP grew its position in LifeStance Health Group by 15.2% in the third quarter. Wellington Management Group LLP now owns 4,830,441 shares of the company's stock worth $33,813,000 after buying an additional 638,385 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of LifeStance Health Group by 82.0% in the second quarter. Dimensional Fund Advisors LP now owns 1,016,452 shares of the company's stock valued at $4,991,000 after buying an additional 457,930 shares in the last quarter. Finally, Parkman Healthcare Partners LLC acquired a new stake in shares of LifeStance Health Group during the 3rd quarter valued at $3,150,000. 85.50% of the stock is currently owned by institutional investors and hedge funds.
About LifeStance Health Group
(
Get Free Report)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
See Also
Before you consider LifeStance Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeStance Health Group wasn't on the list.
While LifeStance Health Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
